Skip to main content
SpringerLink
Log in

Cardiac transthyretin/leukocyte chemotactic factor (LECT) 2 double amyloidosis in a patient suffering from heart failure

  • Letter to the Editors
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Larsen CP, Walker PD, Weiss DT, Solomon A (2010) Prevalence and morphology of leukocyte chemotactic factor 2-associated amyloid in renal biopsies. Kidney Int 77(9):816–819

    Article  CAS  PubMed  Google Scholar 

  2. Benson MD (2010) LECT2 amyloidosis. Kidney Int 77(9):757–759

    Article  CAS  PubMed  Google Scholar 

  3. Larsen CP, Kossmann RJ, Beggs ML, Solomon A, Walker PD (2014) Clinical, morphologic, and genetic features of renal leukocyte chemotactic factor 2 amyloidosis. Kidney Int 86(2):378–382

    Article  CAS  PubMed  Google Scholar 

  4. Ong HT, Tan PK, Wang SM et al (2011) The tumor suppressor function of LECT2 in human hepatocellular carcinoma makes it a potential therapeutic target. Cancer Gene Ther 18(6):399–406

    Article  CAS  PubMed  Google Scholar 

  5. Lu XJ, Chen J, Yu CH et al (2013) LECT2 protects mice against bacterial sepsis by activating macrophages via the CD209a receptor. J Exp Med 210(1):5–13

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Damlaj M, Amre R, Wong P, How J (2014) Hepatic ALECT-2 amyloidosis causing portal hypertension and recurrent variceal bleeding: a case report and review of the literature. Am J Clin Pathol 141(2):288–291

    Article  PubMed  Google Scholar 

  7. Larsen CP, Beggs ML, Wilson JD, Lathrop SL (2016) Prevalence and organ distribution of leukocyte chemotactic factor 2 amyloidosis (ALECT2) among decedents in New Mexico. Amyloid 23(2):119–123

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Vogelsberg H, Mahrholdt H, Deluigi CC et al (2008) Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol 51(10):1022–1030

    Article  PubMed  Google Scholar 

  9. Gillmore JD, Maurer MS, Falk RH et al (2016) Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 133(24):2404–2412

    Article  CAS  PubMed  Google Scholar 

  10. Casadonte R, Kriegsmann M, Deininger SO et al (2015) Imaging mass spectrometry analysis of renal amyloidosis biopsies reveals protein co-localization with amyloid deposits. Anal Bioanal Chem 407(18):5323–5331

    Article  CAS  PubMed  Google Scholar 

  11. Linke RP (2012) On typing amyloidosis using immunohistochemistry. Detailled illustrations, review and a note on mass spectrometry. Prog Histochem Cytochem 47(2):61–132

    Article  PubMed  Google Scholar 

  12. Murphy CL, Wang S, Kestler D et al (2010) Leukocyte chemotactic factor 2 (LECT2)-associated renal amyloidosis: a case series. Am J Kidney Dis 56(6):1100–1107

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Vrana JA, Gamez JD, Madden BJ et al (2009) Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood 114(24):4957–4959

    Article  CAS  PubMed  Google Scholar 

  14. Kriegsmann J, Kriegsmann M, Casadonte R (2015) MALDI TOF imaging mass spectrometry in clinical pathology: a valuable tool for cancer diagnostics (review). Int J Oncol 46(3):893–906

    Article  CAS  PubMed  Google Scholar 

  15. Casadonte R, Caprioli RM (2011) Proteomic analysis of formalin-fixed paraffin-embedded tissue by MALDI imaging mass spectrometry. Nat Protoc 6(11):1695–1709

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Li A, Sowder RC, Henderson LE et al (2001) Chemical cleavage at aspartyl residues for protein identification. Anal Chem 73(22):5395–5402

    Article  CAS  PubMed  Google Scholar 

  17. Leung N, Nasr SH, Sethi S (2012) How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing. Blood 120(16):3206–3213

    Article  CAS  PubMed  Google Scholar 

  18. Kowalski A, Cabrera J, Nasr S, Lerma E (2015) Renal LECT2 amyloidosis: a newly described disorder gaining greater recognition. Clin Nephrol 84(4):236–240

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank Dr. Reinhold P. Linke (Munich, Germany) for additional subtyping analysis using the amyloid antibody kit “amY-kit” and his valuable contribution to the manuscript.

Funding

N/A.

Author information

Authors and Affiliations

  1. Department of Cardiology and Angiology, Eberhard Karls Universität Tübingen, Tübingen, Germany

    Simon Greulich & Meinrad Gawaz

  2. Department of Cardiology and Angiology, Robert Bosch Medical Center, Auerbachstrasse 110, 70376, Stuttgart, Germany

    Heiko Mahrholdt & Raffi Bekeredjian

  3. Proteopath GmbH, Trier, Germany

    Rita Casadonte & Joerg Kriegsmann

  4. Institute of Laboratory Medicine and Human Genetics, Singen, Germany

    Lars Steinmüller-Magin & Frithjof Blessing

  5. Department of Nephrology, Klinikum Stuttgart, Stuttgart, Germany

    Joerg Latus

  6. Cardiopathology, Institute for Pathology and Neuropathology, Eberhard Karls Universität Tübingen, Tübingen, Germany

    Karin Klingel

Authors
  1. Simon Greulich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Heiko Mahrholdt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rita Casadonte
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lars Steinmüller-Magin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Joerg Latus
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Frithjof Blessing
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Joerg Kriegsmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Raffi Bekeredjian
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Meinrad Gawaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Karin Klingel
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

SG, HM, RC, and KK contributed to the idea and design of the report, acquired and analyzed the data, and wrote the report. LSM, JL, FB, and JK contributed to the design of the study, analysis of the data, and revision of the report. RB and MG revised the report. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Heiko Mahrholdt.

Ethics declarations

Conflict of interest

All authors declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Greulich, S., Mahrholdt, H., Casadonte, R. et al. Cardiac transthyretin/leukocyte chemotactic factor (LECT) 2 double amyloidosis in a patient suffering from heart failure. Clin Res Cardiol 112, 444–449 (2023). https://doi.org/10.1007/s00392-022-02045-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-022-02045-8

Search

Navigation